Generic placeholder image

Letters in Organic Chemistry

Editor-in-Chief

ISSN (Print): 1570-1786
ISSN (Online): 1875-6255

Research Article

Synthesis, Spectral Characterization, In silico Docking and ADME Prediction and Biological Evaluation of Novel Piperidin-4-one Derivatives

Author(s): Muthuvel Ramanathan Ezhilarasi* and Mannathusamy Gopalakrishnan

Volume 20, Issue 4, 2023

Published on: 09 December, 2022

Page: [337 - 346] Pages: 10

DOI: 10.2174/1570178620666221021104217

Price: $65

Abstract

A novel series of 2, 6-diaryl-3-(4-methylpiperazin-1-yl) piperidin-4-one (2a-2f) derivatives was synthesized. All the synthesized compounds were characterized by FT-IR, NMR, Mass spectrum, and CHN analysis. NMR spectral analyses were performed unambiguously by their one-dimensional (1H NMR and 13C NMR) and two-dimensional (1H-1H COSY and 1H-13C HSQC) NMR. From the NMR spectral data, the compounds (2a-2f) were found to have normal chair conformation with an equatorial orientation of all the phenyl groups at C-2 and C-6 and the piperazine ring at C-3. The target compounds 2a-2f were subjected to in silico docking and ADME prediction. From the result of in silico docking study, compound 2d showed a good docking score (-8.2 kcal/mol) compared to the standard drug ciprofloxacin (-7.8 kcal/mol). The synthesized piperidine-4-one compounds (2a-2f) demonstrated good to moderate activity against gram-positive and gram-negative strains. From the result of in silico ADME prediction, most of the compounds exhibited good drug scores and druglikeness properties.

Keywords: 1H-1H COSY, 1H-13C HSQC NMR, 1-chloropropan-2-one, ADME, molecular docking study, antimicrobial activity.

Graphical Abstract
[1]
Barondi, M.; Robert, J. Luu-Duc. J. Steroid Biochem. Mol. Biol., 1996, 73-77.
[2]
Subbuperumal, S.M.; Selvaraju, S. Chem. Pharm. Bull. (Tokyo), 2006, 54(6), 795-801.
[http://dx.doi.org/10.1248/cpb.54.795] [PMID: 16755046]
[3]
Takeuchi, Y.; Azuma, K.; Takakura, K.; Abe, H.; Harayama, T. Chem. Commun. (Camb.), 2000, (17), 1643-1644.
[http://dx.doi.org/10.1039/b005028h]
[4]
EI-Subbagh, H.I.; Abu-Zaid, S.M.; Mahran, M.A.; Badria, F.A.; Al-obaid, A.M. J. Med. Chem., 2000, 43, 2915-2921.
[http://dx.doi.org/10.1021/jm000038m] [PMID: 10956199]
[5]
Jerom, B.R.; Spencer, K.H. Eur. Pat Appl. EP, 1988, 1988, 277794.
[6]
Youssouf, M.S.; Kaiser, P.; Singh, G.D.; Singh, S.; Bani, S.; Gupta, V.K.; Satti, N.K.; Suri, K.A.; Johri, R.K. Int. Immunopharmacol., 2008, 8(7), 1049-1055.
[http://dx.doi.org/10.1016/j.intimp.2008.03.015] [PMID: 18486917]
[7]
Gasse, C.; Douguet, D.; Huteau, V.; Marchal, G.; Munier-Lehmann, H.; Pochet, S. Bioorg. Med. Chem., 2008, 16(11), 6075-6085.
[http://dx.doi.org/10.1016/j.bmc.2008.04.045] [PMID: 18467107]
[8]
Domany, G.Y.; Barta-Szalai, G.; Palori, E.; Szabo, S.; Schoen, I. Arzneimettelforschung, 1994, 44, 989.
[9]
Kanagarajan, V.; How, G.A.; Siu, C.N.; Gopalakrishnan, M. J. Heterocycl. Chem., 2013, 396-402.
[http://dx.doi.org/10.1002/jhet.1046]
[10]
Ferreira, L.L.; Andricopulo, A.D. Drug Discov. Today, 2019, 24, 1157-1165.
[http://dx.doi.org/10.1016/j.drudis.2019.03.015] [PMID: 30890362]
[11]
Geneste, P.; Kamenka, J.M.; Hugon, I.; Graffin, P. J. Org. Chem., 1976, 41(22), 3637-3640.
[http://dx.doi.org/10.1021/jo00884a040]
[12]
Caldwell, C.W.; Gauthier, A.D.; Grew, M.N. Magn. Peson. Chem., 1993, 31, 309.
[13]
Ozkan, H.; Adem, S. Disc, 2020, 5, 5422-5428.
[http://dx.doi.org/10.1002/slct.202001123]
[14]
Ali, A.; El Badawy, M.; Shah, R.; Rehman, W.; El Ashry, E-S.H.; Tahir, N. Der Chemical Sinica, 2017, 8(4), 446-460.
[15]
Ferraria, L.G.; Santos, R.N.D.; Oliva, G. Andricopulo. Molecules, 2015, 20, 13384-13421.
[http://dx.doi.org/10.3390/molecules200713384]
[16]
Sharma, D.; Kumar, S.; Narasimhan, B.; Ramasamy, K.; Lim, S.M.; Shah, S.A.A.; Mani, V. BMC Chem., 2019, 13, 60.
[http://dx.doi.org/10.1186/s13065-019-0575-x] [PMID: 31384808]
[17]
Muchtaridi, M.; Dermawan, D.; Yusuf, M. J. Young Pharm., 2018, 10(3), 252-259.
[http://dx.doi.org/10.5530/jyp.2018.10.58]
[18]
Liao, C.; Sitzmann, M.; Pugliese, A.; Nicklaus, M.C. Future Med. Chem., 2011, 3(8), 1057-1085.
[http://dx.doi.org/10.4155/fmc.11.63] [PMID: 21707404]
[19]
Sri, D.R.; Ranjitha, R. Sripathi; Ali Muhammad, KS.; Ravi, S. Asian J. Pharm. Clin. Res., 2016, 9(5), 121-125.
[20]
Chinnamanaikar, R.; Ezhilarasi, M.R.; Prabha, B. Kulandhaivel. Asian J. Chem., 2018, 30(4), 783-789.
[21]
Roney, M.; Fadhlizil, M.; Aluwi, F.M.; Laman, Fuad.; Bhuiyan, AKM.; Ahmed, M.; Huq, Moyeenul. J. Comput. Biophys. Chem, 2022.
[22]
Ding, T.; Li, T.; Li, J. J. Appl. Microbiol., 2019, 10, 10-12.
[23]
Cui, J.; Orton, D. Carbohydr. Res., 1998, 309, 319-330.
[http://dx.doi.org/10.1016/S0008-6215(98)00141-4]
[24]
Mahesh, S.; Bhoi, M.N.; Rathwa, S.K.; Shetty, S.S. J. Mol. Struct., 2019, 1181, 383-402.
[25]
Mathew, M.; Chinnamanayakar, R.; Ramanathan, E.M. Asian J. Chem., 2020, 32(6), 1482-1490.
[http://dx.doi.org/10.14233/ajchem.2020.22634]
[26]
Rathinamanivannan, S.; Mega, K.; Chinnamanayakar, R.; Kumar, A.; Ezhilarasi, M.R. Asian J. Chem., 2019, 31(10), 2191-2196.
[http://dx.doi.org/10.14233/ajchem.2019.22082]
[27]
Chinnamanayakar, R.; Ezhilarasi, M.R. Asian J. Chem., 2019, 31(6), 1311-1320.
[http://dx.doi.org/10.14233/ajchem.2019.21915]
[28]
Kanagarajan, V.; Thanusu, J.; Gopalakrishnan, M. J. Enzyme Inhib. Med. Chem., 2011, 26(1), 67-77.
[http://dx.doi.org/10.3109/14756361003691878] [PMID: 20583857]
[29]
Chinnamanayakar, R.; Ramanathan, E.M. Biointerface Res. Appl. Chem., 2021, 11(1), 8266-8282.

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy